Search Results - A. Risitano
- Showing 1 - 10 results of 10
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
P833: CATEGORIZING HEMATOLOGICAL RESPONSE TO PEGCETACOPLAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A POST HOC ANALYSIS OF THE PHASE 3 PRINCE STUDY DATA by A. Risitano, R. Wong, M. Al-Adhami, J. Savage, R. Horneff, R. Peffault de Latour
Published in HemaSphere (2022-06-01)Get full text
Article -
9
P825: FACTOR D INHIBITION WITH ORAL BCX9930 MONOTHERAPY LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA NAÏV... by A. McDonald, J. L. R. Malherbe, A. Kulasekararaj, W. Füreder, M. Griffin, M. Cornpropst, M. K. Farmer, D. Kargl, D. Collins, W. Sheridan, A. Risitano
Published in HemaSphere (2022-06-01)Get full text
Article -
10
P826: FACTOR D INHIBITION WITH ORAL BCX9930 LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CON... by A. Kulasekararaj, W. Füreder, A. McDonald, J. L. R. Malherbe, S. Gandhi, D. Collins, M. Cornpropst, S. Dobo, M. K. Farmer, D. Kargl, W. Sheridan, M. Griffin, A. Risitano
Published in HemaSphere (2022-06-01)Get full text
Article
